149 related articles for article (PubMed ID: 38389061)
1. A nomogram for predicting adverse pathologic features in low-risk papillary thyroid microcarcinoma.
Gong L; Li P; Liu J; Liu Y; Guo X; Liang W; Lv B; Su P; Liang K
BMC Cancer; 2024 Feb; 24(1):244. PubMed ID: 38389061
[TBL] [Abstract][Full Text] [Related]
2. Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma.
Qiu P; Guo Q; Pan K; Lin J
BMC Cancer; 2024 Feb; 24(1):235. PubMed ID: 38378515
[TBL] [Abstract][Full Text] [Related]
3. Predictive Value of Ultrasound Imaging Characteristics and a BRAF V600E Nomogram for Central Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.
Zhu D; Wu X; Zhang L; Chen Z
Altern Ther Health Med; 2023 Nov; 29(8):139-143. PubMed ID: 37632946
[TBL] [Abstract][Full Text] [Related]
4. Nomogram based on radiomics analysis of ultrasound images can improve preoperative
Tang J; Jiang S; Ma J; Xi X; Li H; Wang L; Zhang B
Front Endocrinol (Lausanne); 2022; 13():915135. PubMed ID: 36060960
[TBL] [Abstract][Full Text] [Related]
5. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
6. Nomogram for Preoperative Estimation of Cervical Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.
Sun J; Jiang Q; Wang X; Liu W; Wang X
Front Endocrinol (Lausanne); 2021; 12():613974. PubMed ID: 33868164
[TBL] [Abstract][Full Text] [Related]
7. BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
Kim KJ; Kim SG; Tan J; Shen X; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Xing M
Eur J Cancer; 2020 Jan; 124():161-169. PubMed ID: 31790974
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
9. Papillary Thyroid Microcarcinoma: A Nomogram Based on Clinical and Ultrasound Features to Improve the Prediction of Lymph Node Metastases in the Central Compartment.
Ye J; Feng JW; Wu WX; Hu J; Hong LZ; Qin AC; Shi WH; Jiang Y
Front Endocrinol (Lausanne); 2021; 12():770824. PubMed ID: 35095755
[TBL] [Abstract][Full Text] [Related]
10. A nomogram for predicting lateral lymph node metastasis in cN0 unifocal papillary thyroid microcarcinoma.
Huang H; Xu S; Ni S; Wang X; Liu S
BMC Cancer; 2023 Aug; 23(1):718. PubMed ID: 37528388
[TBL] [Abstract][Full Text] [Related]
11. Predicting factors of central lymph node metastasis and BRAF
Zhou SL; Guo YP; Zhang L; Deng T; Xu ZG; Ding C; Sun WC; Zhao YW; Kong LF
World J Surg Oncol; 2021 Jul; 19(1):211. PubMed ID: 34256769
[TBL] [Abstract][Full Text] [Related]
12. The relationship between the BRAF(V600E) mutation in papillary thyroid microcarcinoma and clinicopathologic factors.
Choi SY; Park H; Kang MK; Lee DK; Lee KD; Lee HS; Kim SW; Lee EN; Hong JC
World J Surg Oncol; 2013 Nov; 11():291. PubMed ID: 24228637
[TBL] [Abstract][Full Text] [Related]
13. BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm.
Silver JA; Bogatchenko M; Pusztaszeri M; Forest VI; Hier MP; Yang JW; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2021 Nov; 50(1):63. PubMed ID: 34742355
[TBL] [Abstract][Full Text] [Related]
14. A nomogram based on ultrasound radiomics for predicting the invasiveness of cN0 single papillary thyroid microcarcinoma.
Zhang M; Lyu S; Yang L; Wei H; Liu R; Wang X; Liu Y; Zhang B; Kwok JKS; Zhang Y
Gland Surg; 2023 Dec; 12(12):1735-1745. PubMed ID: 38229850
[TBL] [Abstract][Full Text] [Related]
15. Predictive nomogram for central lymph node metastasis in papillary thyroid microcarcinoma based on pathological and ultrasound features.
Wang D; Hu J; Deng C; Yang Z; Zhu J; Su X
Front Endocrinol (Lausanne); 2023; 14():1108125. PubMed ID: 37484943
[TBL] [Abstract][Full Text] [Related]
16. Web-Based Ultrasonic Nomogram Predicts Preoperative Central Lymph Node Metastasis of cN0 Papillary Thyroid Microcarcinoma.
Huang C; Cong S; Shang S; Wang M; Zheng H; Wu S; An X; Liang Z; Zhang B
Front Endocrinol (Lausanne); 2021; 12():734900. PubMed ID: 34557165
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of an individualized nomogram for predicting the high-volume (> 5) central lymph node metastasis in papillary thyroid microcarcinoma.
Wei X; Min Y; Feng Y; He D; Zeng X; Huang Y; Fan S; Chen H; Chen J; Xiang K; Luo H; Yin G; Hu D
J Endocrinol Invest; 2022 Mar; 45(3):507-515. PubMed ID: 34491546
[TBL] [Abstract][Full Text] [Related]
18. A novel nomogram for identifying high-risk patients among active surveillance candidates with papillary thyroid microcarcinoma.
Zhang L; Wang P; Li K; Xue S
Front Endocrinol (Lausanne); 2023; 14():1185327. PubMed ID: 37780614
[TBL] [Abstract][Full Text] [Related]
19. Association of BRAF
Attia AS; Hussein M; Issa PP; Elnahla A; Farhoud A; Magazine BM; Youssef MR; Aboueisha M; Shama M; Toraih E; Kandil E
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555268
[TBL] [Abstract][Full Text] [Related]
20. Treatment strategies and predicting lymph node metastasis in elderly patients with papillary thyroid microcarcinoma.
Li W; Tang Y; Li J; Han W; Wang D; Wang Y
Medicine (Baltimore); 2021 May; 100(18):e25811. PubMed ID: 33950985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
